Bisoprolol

Name: Bisoprolol
Brand: Selleck Chemicals
SKU: S5942
Rating: 5 (1 reviews)

Catalog No.S5942 Purity: 98.91%

Bisoprolol is a cardioselective β1-adrenergic blocking agent used for secondary prevention of myocardial infarction (MI), heart failure, angina pectoris and mild to moderate hypertension.

Bisoprolol Chemical Structure

CAS: 66722-44-9

Selleck's Bisoprolol has been cited by 1 publication

Purity & Quality Control

Batch: S594201 Purity: 98.91%

98.91

Bisoprolol Related Products

Related Targets	α-adrenergic receptor β-adrenergic receptor Beta-Adrenergic Receptor	Click to Expand
Related Products	Mirabegron Propranolol HCl Epinephrine bitartrate Phenylephrine HCl Salbutamol (Albuterol) Sulfate Zenidolol (ICI-118551) Hydrochloride Carvedilol Isoprenaline (Isoproterenol) HCl Bisoprolol fumarate Doxazosin Mesylate (−)-Norepinephrine Yohimbine HCl L755507 Sotalol HCl Nebivolol hydrochloride (R-65824) Dexmedetomidine HCl Nebivolol Salmeterol Xylazine Isoproterenol sulfate dihydrate Atipamezole Salmeterol Xinafoate Higenamine hydrochloride Terbutaline Sulfate Epinephrine HCl Carvedilol Phosphate Vilanterol Trifenate Guanabenz Acetate Indacaterol Ivabradine HCl Betaxolol Metoprolol Atenolol Salbutamol Clonidine HCl Tizanidine Acebutolol HCl Fenoterol hydrobromide Timolol Maleate Tolazoline HCl Terazosin HCl Dihydrate Medetomidine HCl Rauwolscine hydrochloride (-)-Isoproterenol hydrochloride Maprotiline HCl Terazosin HCl Prazosin Dronedarone Indacaterol Maleate Nadolol Deoxycorticosterone acetate Betaxolol HCl Detomidine HCl Naftopidil Phentolamine Mesylate Cisatracurium Besylate	Click to Expand
Related Compound Libraries	FDA-approved Drug Library Natural Product Library Neuronal Signaling Compound Library CNS-Penetrant Compound Library Anti-alzheimer Disease Compound Library	Click to Expand

Signaling Pathway

Adrenergic Receptor Signaling Pathway

Choose Selective Adrenergic Receptor Inhibitors

Biological Activity

Description	Bisoprolol is a cardioselective β1-adrenergic blocking agent used for secondary prevention of myocardial infarction (MI), heart failure, angina pectoris and mild to moderate hypertension.

NCT Number	Recruitment	Conditions	Sponsor/Collaborators	Start Date	Phases
Clinical Trial Information (data from https://clinicaltrials.gov, updated on 2024-01-11)
NCT05880056	Not yet recruiting	Essential Hypertension	Genuine Research Center Egypt\|Nerhadou International for pharmaceutical & Nutraceutical Egypt	July 15 2023	Phase 4
NCT06004453	Recruiting	Heart Failure	Novartis Pharmaceuticals\|Novartis	April 5 2023	--
NCT05536284	Completed	Acute Coronary Syndrome	Damanhour University\|Alexandria University	September 1 2021	Phase 2
NCT05730413	Recruiting	Coronary Artery Bypass Grafting\|Postoperative Atrial Fibrillation\|Coronary Artery Disease	Cairo University	August 25 2021	Phase 4
NCT04656847	Completed	Coronary Artery Disease\|Myocardial Infarction\|Arterial Hypertension	Servier Russia	March 1 2021	--
NCT03730116	Completed	Arterial Hypertension\|CHD - Coronary Heart Disease	Servier Russia	November 14 2018	--

Chemical Information & Solubility

Molecular Weight	325.44	Formula	C₁₈H₃₁NO₄
CAS No.	66722-44-9	SDF	--
Density	1.033 g/mL
Smiles	CC(C)NCC(COC1=CC=C(C=C1)COCCOC(C)C)O
Storage (From the date of receipt)	2 years -20°C liquid	Storage of Stock Solutions Aliquot the stock solutions to avoid repeated freeze-thaw cycles	1 year-80°Cin solvent
Storage (From the date of receipt)	2 years -20°C liquid		1 month-20°Cin solvent

In vitro
Batch:

Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.

In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Dilution Calculator Molecular Weight Calculator

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

Dosage: mg/kg Average weight of animals: g Dosing volume per animal:μL Number of animals:

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO + % + % Tween 80 + % ddH₂O

%DMSO+ %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH₂O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

C1=C0/X	C1:	LOG(C1):
C2=C1/X	C2:	LOG(C2):
C3=C2/X	C3:	LOG(C3):
C4=C3/X	C4:	LOG(C4):
C5=C4/X	C5:	LOG(C5):
C6=C5/X	C6:	LOG(C6):
C7=C6/X	C7:	LOG(C7):
C8=C7/X	C8:	LOG(C8):